TOP OF MIND: What directors are thinking
By Directors and Boards

Stacey Hallerman

Director, MedMen

As the axiom goes, serving as a director is a part-time job with full-time responsibilities. That principle is particularly applicable to directors of newly public companies. And it’s even more relevant for directors of companies in the fast-developing cannabis industry.

On the heels of several states legalizing the sale of cannabis in recent years, a thriving yet complex new industry has emerged. Investors’ interest is mounting but so, too, is their collective focus on cannabis companies able to demonstrate credibility in an emerging space with an evolving regulatory landscape. 

Against that backdrop, cannabis companies with boards that boast strong corporate governance practices and the diverse skills necessary to oversee dynamic operations in a complex operating environment give investors comfort and added reason to invest.

MedMen is a case in point. Since going public, the leading U.S. cannabis company has focused on building a board with governance expertise and wide-ranging skill sets. Its determination to get things right on these fronts played a big role in my decision to join MedMen’s board. The company strives to implement best practices across every aspect of its operations. The board is in its early days, but MedMen is committed to ensuring its directors amplify this company rule.

As a director of MedMen, I am one of eight board members, five of whom are independent. Collectively, our board has expertise in cannabis, consumer goods, luxury brands, retail, capital markets, legal, finance and tax, among others. We are tasked to understand the cannabis industry, and to both learn and address what matters most to our investors and other stakeholders.

 In the cannabis sector, directors must proactively seek out the information they need to fully understand the changing landscape and the competitive dynamics that impact the companies they govern. They also must partner closely with MedMen’s management team to ensure that the company’s strategic plans are aligned with the goal of creating long-term value for shareholders.  In these ways, a board can prove a genuine asset that complements the strategic planning of management, creating a competitive advantage.

Stacey Hallerman was vice president, chief legal counsel and corporate secretary at Richemont North America, part of the global luxury conglomarate that owns iconic brands such as Cartier, Chloe, Van Cleef & Arpels and Montblanc. She was also senior corporate counsel at Pfizer.

 


Issue: 
2018 Third Quarter

Other related articles

  • “Being Black in Corporate America” Deserves a Response
    Published June 05, 2020
    By Directors and Boards
    Authors Note This essay was prepared before the death of George Floyd and the protests and important public discussions that followednbsp If anything it is even more relevant nowThe Center for Talent ...
  • Director Data Q2 2020
    Published April 21, 2020
    By Directors and Boards
    Leadership Independence for SV 150 Majority Voting for SampP 100Since 2002 Fenwick amp West has surveyed the corporate governance practices of the companies included in the Standard amp Poors 100 Inde ...
  • Top of Mind: Dawn Zier, Director, Hain Celestial Group and Spirit Airlines
    Published April 21, 2020
    By Dawn Zier
    As we emerge from the pandemic we will find permanent changes and shifts in the way we do business which will force management teams and boards to navigate a new normal From dislocation and disruption ...
  • Wargaming Risk: What Military Leaders Bring to the Table
    Published April 21, 2020
    By April Hall
    When the going gets tough its easy to fall back on language that refers to war Often people are on the front line or taking on a challenge is a battle Over the years the United States has waged war on ...